The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases - PubMed (original) (raw)
Comparative Study
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
N Roy et al. EMBO J. 1997.
Abstract
The inhibitor of apoptosis (IAP) family of proteins are highly conserved through evolution. However, the mechanisms by which these proteins interfere with apoptotic cell death have been enigmatic. Recently, we showed that one of the human IAP family proteins, XIAP, can bind to and potently inhibit specific cell death proteases (caspases) that function in the distal portions of the proteolytic cascades involved in apoptosis. In this study, we investigated three of the other known members of the human IAP family, c-IAP-1, c-IAP-2 and NAIP. Similarly to XIAP, in vitro binding experiments indicated that c-IAP-1 and c-IAP-2 bound specifically to the terminal effector cell death proteases, caspases-3 and -7, but not to the proximal protease caspase-8, caspases-1 or -6. In contrast, NAIP failed to bind tightly to any of these proteases. Recombinant c-IAP-1 and c-IAP-2 also inhibited the activity of caspases-3 and -7 in vitro, with estimated Kis of <=0.1 microM, whereas NAIP did not. The BIR domain-containing region of c-IAP-1 and c-IAP-2 was sufficient for inhibition of these caspases, though proteins that retained the RING domain were somewhat more potent. Utilizing a cell-free system in which caspases were activated in cytosolic extracts by addition of cytochrome c, c-IAP-1 and c-IAP-2 inhibited both the generation of caspase activities and proteolytic processing of pro-caspase-3. Similar results were obtained in intact cells when c-IAP-1 and c-IAP-2 were overexpressed by gene transfection, and apoptosis was induced by the anticancer drug, etoposide. Cleavage of c-IAP-1 or c-IAP-2 was not observed when interacting with the caspases, implying a different mechanism from the baculovirus p35 protein, the broad spectrum suicide inactivator of caspases. Taken together, these findings suggest that c-IAP-1 and c-IAP-2 function similarly to XIAP by inhibiting the distal cell death proteases, caspases-3 and -7, whereas NAIP presumably inhibits apoptosis via other targets.
Similar articles
- IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.
Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC. Deveraux QL, et al. EMBO J. 1998 Apr 15;17(8):2215-23. doi: 10.1093/emboj/17.8.2215. EMBO J. 1998. PMID: 9545235 Free PMC article. - IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. Tamm I, et al. Cancer Res. 1998 Dec 1;58(23):5315-20. Cancer Res. 1998. PMID: 9850056 - A single BIR domain of XIAP sufficient for inhibiting caspases.
Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC. Takahashi R, et al. J Biol Chem. 1998 Apr 3;273(14):7787-90. doi: 10.1074/jbc.273.14.7787. J Biol Chem. 1998. PMID: 9525868 - Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M, Qadir MI, Perveen N, Ahmad B, Saleem U, Irshad T, Ahmad B. Saleem M, et al. Chem Biol Drug Des. 2013 Sep;82(3):243-51. doi: 10.1111/cbdd.12176. Chem Biol Drug Des. 2013. PMID: 23790005 Review. - The IAP family: endogenous caspase inhibitors with multiple biological activities.
Yang YL, Li XM. Yang YL, et al. Cell Res. 2000 Sep;10(3):169-77. doi: 10.1038/sj.cr.7290046. Cell Res. 2000. PMID: 11032169 Review.
Cited by
- Exploring apoptotic induction of malabaricone A in triple-negative breast cancer cells: an acylphenol phyto-entity isolated from the fruit rind of Myristica malabarica Lam.
Vimalkumar PS, Sivadas N, Murali VP, Sherin DR, Murali M, Joseph AG, Radhakrishnan KV, Maiti KK. Vimalkumar PS, et al. RSC Med Chem. 2024 Sep 9;15(10):3558-75. doi: 10.1039/d4md00391h. Online ahead of print. RSC Med Chem. 2024. PMID: 39263684 - Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy.
Duan R, Milton P, Sittplangkoon C, Liu X, Sui Z, Boyce BF, Yao Z. Duan R, et al. Cancer Immunol Immunother. 2024 Aug 6;73(10):203. doi: 10.1007/s00262-024-03788-1. Cancer Immunol Immunother. 2024. PMID: 39105847 Free PMC article. - Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation.
Cao Y, Lu C, Beeraka NM, Efetov S, Enikeev M, Fu Y, Yang X, Basappa B, He M, Li Z. Cao Y, et al. Front Immunol. 2024 Jul 2;15:1428920. doi: 10.3389/fimmu.2024.1428920. eCollection 2024. Front Immunol. 2024. PMID: 39015566 Free PMC article. Review. - Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells.
Glebavičiūtė G, Vijaya AK, Preta G. Glebavičiūtė G, et al. Biology (Basel). 2024 Jun 19;13(6):455. doi: 10.3390/biology13060455. Biology (Basel). 2024. PMID: 38927335 Free PMC article. - Anticancer Activity and Molecular Mechanisms of Acetylated and Methylated Quercetin in Human Breast Cancer Cells.
Sakao K, Hamamoto S, Urakawa D, He Z, Hou DX. Sakao K, et al. Molecules. 2024 May 20;29(10):2408. doi: 10.3390/molecules29102408. Molecules. 2024. PMID: 38792269 Free PMC article.
References
- EMBO J. 1996 Oct 15;15(20):5504-12 - PubMed
- Nature. 1995 Sep 21;377(6546):248-51 - PubMed
- Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13973-8 - PubMed
- Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14486-91 - PubMed
- Nature. 1997 Jan 2;385(6611):86-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous